TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33798310

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy (regulating menstruation and promoting pregnancy) at Baihui (GV 20), Shenting (GV 24), Guanyuan (CV 4), Sanyinjiao (SP 6), Shenshu (BL 23), Ciliao (BL 32), once a day, 5 times a week for 3 months.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western medication (oral administration of climen, 1 tablet a day for 21 days, stopped for 1 week as a course, required 3 consecutive courses).
Number of subjects: 60
Study: 34478879

Group type: EXPERIMENTAL
Intervention: Skipping breakfast ≥ 3 days/week (n = 102)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Skipping lunch ≥ 3 days/week
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Skipping dinner ≥ 1 day/week
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Nonstandard shifts
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Meal skipping
Number of subjects: 602
Study: 33528744

Group type: EXPERIMENTAL
Intervention: Tweets without misinformation
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Tweets from organizations
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Tweets about effectiveness
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Tweets with misinformation
Number of subjects: 1206
Study: 35576620

Group type: EXPERIMENTAL
Intervention: Training provided by healthcare professional
Number of subjects: 22

Group type: COMPARATOR
Intervention: Training provided by caregivers
Number of subjects: 22
Study: 34962984

Group type: EXPERIMENTAL
Intervention: Polypill
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polypill plus aspirin
Number of subjects: 0
Study: 32908704

Group type: EXPERIMENTAL
Intervention: Completion of continuum of maternal healthcare services
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Ability to read and write
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Using car/motorcycle as a means of transportation
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Travel time less than an hour to health facility
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Satisfaction with service delivery
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Receiving health education on maternal healthcare services in the last 6 months
Number of subjects: 565
Study: 34234209

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 361194

Group type: EXPERIMENTAL
Intervention: Smoking initiation (positive control)
Number of subjects: 361194

Group type: COMPARATOR
Intervention: Absorbate (negative control)
Number of subjects: 361194
Study: 35184667

Group type: EXPERIMENTAL
Intervention: Home-delivered auditory training with live-voice conversations in the presence of a single-talker distractor (30 min/day, 5 days/week over 4 weeks)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Home-delivered auditory training with live-voice conversations in quiet (active-control group)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Home-delivered auditory training with live-voice conversations in the presence of a single-talker distractor
Number of subjects: 39
Study: 34429152

Group type: EXPERIMENTAL
Intervention: Peficitinib 100 mg
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Peficitinib 150 mg
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1025
Study: 32207416

Group type: EXPERIMENTAL
Intervention: Peer debriefing using Pendleton's method (Group B)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Facilitator-led demonstration (Group A)
Number of subjects: 84
Study: 34787762

Group type: EXPERIMENTAL
Intervention: Conventional periodontal treatment associated with 10 laser applications by the ILIB‐Modified (ILIB‐M) technique
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional periodontal therapy
Number of subjects: 21
Study: 33011964

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 3275

Group type: EXPERIMENTAL
Intervention: Apixaban (all patients from AVERROES to open-label extension)
Number of subjects: 3275
Study: 32532654

Group type: EXPERIMENTAL
Intervention: Ramelteon (8 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 35772622

Group type: EXPERIMENTAL
Intervention: Antimicrobial Photodynamic Therapy (aPDT) with 300 µmol/L of methylene blue
Number of subjects: 108

Group type: COMPARATOR
Intervention: Antimicrobial Photodynamic Therapy (aPDT) with 8 µmol/L of curcumin
Number of subjects: 108
Study: 35387778

Group type: EXPERIMENTAL
Intervention: Clear lens extraction (CLE)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Laser peripheral iridotomy (LPI)
Number of subjects: 369
Study: 33592830

Group type: EXPERIMENTAL
Intervention: Tourniquet group (group 1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tourniquet free group (group 2)
Number of subjects: 20
Study: 34565261

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 0
Study: 32753699

Group type: EXPERIMENTAL
Intervention: IgG antibodies against non-self glycans
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: IgG antibodies against self glycans
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Anti-self glycan IgG antibodies with simultaneous IgM presence
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Anti-self glycan A subgroup (GM2/GM1/GD1b)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Anti-self glycan B subgroup (GM3/GD1a/GD3/GT1b/GQ1b)
Number of subjects: 27
Study: 35623863

Group type: EXPERIMENTAL
Intervention: Ziziphus jujube (30 g daily for 12 weeks)
Number of subjects: 48
Study: 34526918

Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied over the left prefrontal cortex during social cognition training for 10 sessions within 2 consecutive weeks.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS applied over the left prefrontal cortex during social cognition training for 10 sessions within 2 consecutive weeks.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Follow-up assessments 1 and 6 months after the intervention.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tolerability evaluated using a standardized questionnaire.
Number of subjects: 20
Study: 34704516

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Copper intrauterine device (Cu-IUD)
Number of subjects: 66
Study: 34807658

Group type: EXPERIMENTAL
Intervention: Mindfulness-based online intervention (ORBIT 2.0)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Psychoeducation control
Number of subjects: 302
Study: 33049054

Group type: EXPERIMENTAL
Intervention: Midostaurin
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: NPM1mut/FLT3-TKDmut or CBF-rearranged/FLT3-TKDmut
Number of subjects: 163
Study: 35168657

Group type: EXPERIMENTAL
Intervention: Casper + spreader group
Number of subjects: 94

Group type: COMPARATOR
Intervention: Casper alone group
Number of subjects: 94
Study: 33907075

Group type: EXPERIMENTAL
Intervention: Electroconvulsive Therapy (ECT)
Number of subjects: 1089

Group type: COMPARATOR
Intervention: Non-Electroconvulsive Therapy (non-ECT)
Number of subjects: 1089

Group type: COMPARATOR
Intervention: Background cohort (randomly selected individuals)
Number of subjects: 1089

Group type: COMPARATOR
Intervention: Non-ECT cohort
Number of subjects: 1089

Group type: COMPARATOR
Intervention: Background cohort
Number of subjects: 1089
Study: 34475137

Group type: EXPERIMENTAL
Intervention: ComHIP (Community-based Hypertension Improvement Project)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard hypertension care
Number of subjects: 0
Study: 32266952

Group type: EXPERIMENTAL
Intervention: Current Fetal Surgery Center (CFSC)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Previous Fetal Surgery Center (PFSC)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: CFSC
Number of subjects: 198

Group type: COMPARATOR
Intervention: PFSC
Number of subjects: 198

Group type: COMPARATOR
Intervention: MOMS
Number of subjects: 198
Study: 36469320

Group type: EXPERIMENTAL
Intervention: Oral sodium butyrate, 20 mg/kg body weight per day for 6 months
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard care for pediatric obesity (placebo)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Oral sodium butyrate
Number of subjects: 54
Study: 33453383

Group type: EXPERIMENTAL
Intervention: Selenite-loaded chitosan nanoparticles (SeChNPs) 0.5 g/kg diet
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Selenite-loaded chitosan nanoparticles (SeChNPs) 1 g/kg diet
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Selenite-loaded chitosan nanoparticles (SeChNPs) 2 g/kg diet
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (basal diet with inorganic selenium)
Number of subjects: 400
Study: 33411186

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA) group
Number of subjects: 91

Group type: COMPARATOR
Intervention: Primary snoring (PS) group
Number of subjects: 91
Study: 33856434

Group type: EXPERIMENTAL
Intervention: Medication group (topical ocular hypotensive medication)
Number of subjects: 1636

Group type: COMPARATOR
Intervention: Observation group (close observation)
Number of subjects: 1636

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 1636

Group type: EXPERIMENTAL
Intervention: Black/African American participants
Number of subjects: 1636

Group type: EXPERIMENTAL
Intervention: Other races
Number of subjects: 1636

Group type: EXPERIMENTAL
Intervention: Low-risk tertile
Number of subjects: 1636

Group type: EXPERIMENTAL
Intervention: Medium-risk tertile
Number of subjects: 1636

Group type: EXPERIMENTAL
Intervention: High-risk tertile
Number of subjects: 1636
Study: 36687222

Group type: EXPERIMENTAL
Intervention: Hematoma-directed ultrasound-guided lumpectomy (HDUGL)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Wire-guided lumpectomy (WGL)
Number of subjects: 25
Study: 32594884

Group type: EXPERIMENTAL
Intervention: Lactulose plus paraffin
Number of subjects: 363

Group type: COMPARATOR
Intervention: Polyethylene glycol
Number of subjects: 363
Study: 32779952

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 1.5 g twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate (MTX) 25 mg weekly
Number of subjects: 0
Study: 35612905

Group type: EXPERIMENTAL
Intervention: Therapeutic VR (EaseVRx)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Sham VR
Number of subjects: 188
Study: 32921136

Group type: EXPERIMENTAL
Intervention: Nasoseptal flap (NSF) elevation
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Nasoseptal flap (NSF) elevation on the side of dominant olfaction
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (EEA without NSF)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Change in rhinologic QOL as determined by Sinonasal Outcomes Test 22
Number of subjects: 31
Study: 32790845

Group type: EXPERIMENTAL
Intervention: rhTPO (300 U/kg once daily from days 14 to 28 after UCBT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 35658857

Group type: EXPERIMENTAL
Intervention: REACT intervention (physical activity and behaviour maintenance)
Number of subjects: 25
Study: 33227408

Group type: EXPERIMENTAL
Intervention: Post-operative chemotherapy (CT)
Number of subjects: 788

Group type: COMPARATOR
Intervention: Post-operative chemoradiotherapy (CRT)
Number of subjects: 788
Study: 34256716

Group type: EXPERIMENTAL
Intervention: Urban adolescents
Number of subjects: 2031

Group type: COMPARATOR
Intervention: Rural adolescents
Number of subjects: 2031

Group type: EXPERIMENTAL
Intervention: Both urban and rural adolescents
Number of subjects: 2031
Study: 32519928

Group type: EXPERIMENTAL
Intervention: Patisiran
Number of subjects: 252
Study: 33979325

Group type: EXPERIMENTAL
Intervention: Preventive chemotherapy (PCT) for soil-transmitted helminths (STH)
Number of subjects: 6102

Group type: EXPERIMENTAL
Intervention: Risk factors associated with STH infection
Number of subjects: 6102

Group type: COMPARATOR
Intervention: Access to sanitation, handwashing facilities, or water facilities
Number of subjects: 6102
Study: 32660575

Group type: EXPERIMENTAL
Intervention: High SOC group (SOC10 > 45)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Working hours
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: SOC10
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Overall burnout
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Burnout in the third month
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Burnout in the fifteenth month
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 97
Study: 34878438

Group type: EXPERIMENTAL
Intervention: TFV IVR
Number of subjects: 22

Group type: COMPARATOR
Intervention: TDF/FTC oral tablets
Number of subjects: 22
Study: 34034612

Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5 mg/d
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Cariprazine 3 mg/d
Number of subjects: 393

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study: 35679127

Group type: EXPERIMENTAL
Intervention: Milled bar overdentures (MO)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fixed restoration (FR)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional dentures (CD)
Number of subjects: 16
Study: 32745532

Group type: EXPERIMENTAL
Intervention: Double high-level disinfection (DHLD)
Number of subjects: 878

Group type: COMPARATOR
Intervention: Liquid chemical sterilization (LCS)
Number of subjects: 878
Study: 32761668

Group type: COMPARATOR
Intervention: CTRL
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: PE
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: PTB
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: IUGR
Number of subjects: 200
Study: 35715764

Group type: EXPERIMENTAL
Intervention: Automated oxygen control
Number of subjects: 58

Group type: COMPARATOR
Intervention: Manual oxygen control
Number of subjects: 58
Study: 36048465

Group type: EXPERIMENTAL
Intervention: Temperature-Controlled Radiofrequency (TCRF) device treatment of the nasal valve
Number of subjects: 108

Group type: COMPARATOR
Intervention: Sham control procedure (no RF energy)
Number of subjects: 108
Study: 32893136

Group type: EXPERIMENTAL
Intervention: Interprofessional medication assessment
Number of subjects: 512

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 512
Study: 33340284

Group type: EXPERIMENTAL
Intervention: Six-month refill intervention ACs
Number of subjects: 2150

Group type: COMPARATOR
Intervention: Standard of care ACs
Number of subjects: 2150
Study: 35623551

Group type: EXPERIMENTAL
Intervention: Splenic vein embolization (SVE)
Number of subjects: 8
Study: 33166026

Group type: EXPERIMENTAL
Intervention: Wi-Fi exposure (2.45 GHz)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 30
Study: 34246324

Group type: EXPERIMENTAL
Intervention: Feeling Safe Programme
Number of subjects: 130

Group type: COMPARATOR
Intervention: Befriending
Number of subjects: 130
Study: 33226875

Group type: EXPERIMENTAL
Intervention: Early Coronary Angiography
Number of subjects: 0

Group type: COMPARATOR
Intervention: No Early Coronary Angiography
Number of subjects: 0
Study: 35903872

Group type: EXPERIMENTAL
Intervention: NEET youth
Number of subjects: 355

Group type: COMPARATOR
Intervention: Non-NEET youth
Number of subjects: 355
Study: 34259467

Group type: EXPERIMENTAL
Intervention: Copper T380A IUD
Number of subjects: 655

Group type: COMPARATOR
Intervention: Levonorgestrel 52‐mg intrauterine system
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Single unprotected intercourse episodes
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Unprotected intercourse 5 or fewer days before IUD placement
Number of subjects: 655
Study: 33314883

Group type: EXPERIMENTAL
Intervention: Retro-walking (RW) with structured resistance training (SRT) 3 times a week for 12 weeks
Number of subjects: 34
Study: 34671041

Group type: EXPERIMENTAL
Intervention: Stylet angulation at the holding position
Number of subjects: 60

Group type: COMPARATOR
Intervention: No stylet angulation at the holding position (non-angulation group)
Number of subjects: 60
Study: 34171293

Group type: EXPERIMENTAL
Intervention: HIIT + R training (8 sessions, 1/week, 30 minutes each session, consisting of ten 3-minute bouts of high-intensity treadmill walking and resistance training)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual Care (conventional medical treatment)
Number of subjects: 90
Study: 33853014

Group type: EXPERIMENTAL
Intervention: Cognitive and emotional remediation training for depression (CERT‐D)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 112
Study: 35042554

Group type: EXPERIMENTAL
Intervention: Plasma-Lyte 148 (Plasmalyte)
Number of subjects: 800

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 800
Study: 32014843

Group type: EXPERIMENTAL
Intervention: Web-based menu planning intervention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 54
Study: 36326113

Group type: EXPERIMENTAL
Intervention: Experimental group reading about a celebration with meatless dishes
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Experimental group emphasizing that the host became a vegetarian after years of religious fasting
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control group reading about a celebration with meat-based meals
Number of subjects: 246
Study: 33500146

Group type: EXPERIMENTAL
Intervention: Balanced crystalloids
Number of subjects: 2029

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 2029
Study: 32104921

Group type: EXPERIMENTAL
Intervention: 2.45 GHz Wi-Fi exposure with a total antenna input power of 220 mW; specific absorption rate (SAR) in cortical brain regions approximately 1-2 mW/kg.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham exposure (control group); details of the sham exposure not specified.
Number of subjects: 0
Study: 34087746

Group type: EXPERIMENTAL
Intervention: Incentive group
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 41
Study: 32216829

Group type: EXPERIMENTAL
Intervention: ABP 710
Number of subjects: 558

Group type: COMPARATOR
Intervention: Infliximab reference product (RP)
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: ABP 710 and RP
Number of subjects: 558
Study: 34528495

Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises for 25 to 30 minutes every day for 4 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 90
Study: 35851283

Group type: EXPERIMENTAL
Intervention: Home-based child care (HBCC) delivered through village health workers (VHWs)
Number of subjects: 7656

Group type: COMPARATOR
Intervention: Control areas (CA)
Number of subjects: 7656
Study: 32854566

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (USG) for catheter insertion at a distance of 4 to 10 cm from wrist joint
Number of subjects: 103

Group type: COMPARATOR
Intervention: Blind insertion of radial artery catheter
Number of subjects: 103
Study: 32959557

Group type: EXPERIMENTAL
Intervention: Penetrating needling at Cuanzhu (BL2) and Yuyao (EX-HN4) combined with perpendicular needling at Shenmai (BL62) for 10 days, 2 courses.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Prednisone acetate (30 mg/d for 5 days, then reduced to 10 mg/d for 1 week) and muscular injection with vitamin B12 (0.5 mg) and B1 (0.1 mg) daily, followed by oral vitamin B1 (10 mg, three times a day for 10 days).
Number of subjects: 64
Study: 33509729

Group type: EXPERIMENTAL
Intervention: Robotic RYGB (R-RYGB)
Number of subjects: 21736

Group type: EXPERIMENTAL
Intervention: Robotic RYGB (R-RYGB) in super-obese patients
Number of subjects: 21736
Study: 32356074

Group type: EXPERIMENTAL
Intervention: CPAP therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham CPAP therapy
Number of subjects: 22
Study: 35182035

Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 8 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 48 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 8 mg (stage 2)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 32 mg (stage 2)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 48 mg (stage 2)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 8-48 mg (both stages)
Number of subjects: 70
Study: 34481972

Group type: EXPERIMENTAL
Intervention: Mediterranean diet with additional extra virgin olive oil (40 mL daily) and pistachios (25 to 30 g daily)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Mediterranean diet (control group)
Number of subjects: 560
Study: 33386906

Group type: EXPERIMENTAL
Intervention: Endovascular coils (EC)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Vascular plugs (VP)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both EC and VP
Number of subjects: 46
Study: 35896299

Group type: EXPERIMENTAL
Intervention: Non-invasive preimplantation genetic testing (ni-PGT)
Number of subjects: 1148

Group type: COMPARATOR
Intervention: Conventional morphology
Number of subjects: 1148
Study: 32149586

Group type: EXPERIMENTAL
Intervention: Error Management Training (EMT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Error Avoidance Training (EAT)
Number of subjects: 42
Study: 36370336

Group type: EXPERIMENTAL
Intervention: Roflumilast 0.3%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Roflumilast 0.15%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Roflumilast (both dosages)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 34732484

Group type: EXPERIMENTAL
Intervention: Custom-made insoles (n=70)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Usual care (n=46)
Number of subjects: 116
Study: 32535403

Group type: EXPERIMENTAL
Intervention: Cardiac autonomic balance (CAB)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control condition (no stressor)
Number of subjects: 96
Study: 36063555

Group type: EXPERIMENTAL
Intervention: Awake prone positioning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33098997

Group type: EXPERIMENTAL
Intervention: 3 months of standard doses of FOLFOX/CAPOX
Number of subjects: 3759

Group type: COMPARATOR
Intervention: 6 months of standard doses of FOLFOX/CAPOX
Number of subjects: 3759